Bilaketaren emaitzak - LOUIS, Edouard
- Erakusten 1 - 20 emaitzak -- 68
- Go to Next Page
-
1
-
2
Stopping Anti-TNF in Crohn's Disease Remitters: Pros and Cons: The Pros nork Louis, Edouard
Argitaratua 2021Text -
3
Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020? nork Gomollón, Fernando, Louis, Edouard
Argitaratua 2021Text -
4
Are we giving biologics too much time? When should we stop treatment? nork Louis, Edouard, Belaiche, J, Reenaers, C
Argitaratua 2008Text -
5
-
6
Tailoring the Treatment to the Individual in Crohn's Disease nork Louis, Edouard, Belaiche, Jacques, Reenaers, Catherine
Argitaratua 2009Text -
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn’s Disease nork Peyrin-Biroulet, Laurent, Louis, Edouard, Loftus, Edward V., Lacerda, Ana, Zhou, Qian, Sanchez Gonzalez, Yuri, Ghosh, Subrata
Argitaratua 2021Text -
18
Anti-TNF Monotherapy for Crohn’s Disease: a 13-year Multicentre Experience nork Peyrin-Biroulet, Laurent, Salleron, Julia, Filippi, Jérôme, Reenaers, Catherine, Antunes, Ophélie, Filipe, Virginie, Louis, Edouard, Hébuterne, Xavier, Roblin, Xavier
Argitaratua 2016Text -
19
A primate-specific retroviral enhancer wires the XACT lncRNA into the core pluripotency network in humans nork Casanova, Miguel, Moscatelli, Madeleine, Chauvière, Louis Édouard, Huret, Christophe, Samson, Julia, Liyakat Ali, Tharvesh Moideen, Rosspopoff, Olga, Rougeulle, Claire
Argitaratua 2019Text -
20